Join the web’s most supportive community of creators and get high-quality tools for hosting, sharing, and streaming videos in gorgeous HD with no ads.

The article discusses a growing trend among Canadian women who are opting for fertility treatments, particularly egg freezing, to prevent passing on genetic mutations such as BRCA 1 to their children. Emma Clayton Jones, a 32-year-old woman with the BRCA 1 mutation, shares her decision to freeze her eggs to enable embryo testing for the genetic condition before starting a family. She explains that after experiencing her own cancer scare, she wants to avoid subjecting her future children to the same health risks. The article notes that while egg freezing is often pursued to preserve fertility for later childbearing due to career, relationship, or financial factors, an increasing number of women are specifically using it to screen for genetic conditions. Fertility doctor Sony Sierra, who runs an egg freezing clinic in Toronto, observes that while conversations about fertility treatments have become more mainstream, significant barriers to accessibility remain. The article highlights that egg freezing typically costs around $8,000 per cycle, with additional medication costs of $2,000-$8,000, and many women require multiple cycles. Public funding for fertility treatments varies by province and generally doesn't cover elective egg freezing, though some workplace benefits are beginning to cover it. The article also addresses ethical concerns around genetic testing, including potential misuse for sex selection (which is illegal in Canada except to prevent sex-linked illnesses), and concerns from disability advocates about the implications of eliminating genetic diversity. Despite these challenges, experts like Dr. Judith Daniluk and Dr. Caitlin Dunne emphasize that genetic testing for health reasons is legal in Canada and that fertility treatments should become more accessible as public awareness grows. The piece concludes with the perspective that fertility issues represent a significant public health concern affecting many people with ovaries, and that making these treatments more accessible is an ongoing challenge.

Folic acid achieves a 36% reduction in neural tube defects across ALL populations—including MTHFR variant carriers. New research confirms that MTHFR genet… #Evidencebasedmedicine #Folicacid #Genetictesting #MTHFR #Neuraltubedefects

Aussie DNA scientists harness nanopore DNA sequencing to create a novel approach to diagnosing inherited muscle diseases. Get the latest with MNB!

Hereditary cancer is often associated with the maternal side of a family, but fathers can pass genetic mutations to their children as often as mothers

An observational study in the UK has just produced substantially positive results for a new, non-invasive, genetic urine test for bladder cancer. Demonstrating extremely high accuracy for negatively diagnosing bladder cancer, it also correctly identified bladder cancer-associated genes in 71 of 77 patients who went on to develop a malignancy. The study authors acknowledged several […] The post Exceptional Detection Rates of Bladder Cancer Recorded in Study of Simple, Yet State-of-the-Art Test appeared first on Good News Network.